Abstract

allergic rhinitis and asthma (ARIA) – disease of inflammatory genesis and often associated with lack of control of these diseases that cause a significant reduction in quality of life for the patient and important social and economic burden [1,2]. According to international recommendations, disease control is a major challenge in the treatment of allergic diseases of respiratory way [1,3]. Guidelines "Allergic rhinitis and its impact on asthma (ARIA)" [1] stressed the importance of a comprehensive approach for assessment and control of ARA. Thus, in the fight against disease, the problem should be considered at the same time as the pathology of the upper and lower respiratory ways [4].Based on definition of control of asthma from the Global initiative of asthma [3], control over a chronic disease can be characterized so: patients feel the minimum symptoms, seldom need preparations of so-called ambulance, all physiological functions are close to norm, so patients don't experience restrictions in activity and extremely seldom have aggravations.By 2009 some questionnaires on quality of life of the patient, symptoms and weight in points [5-9], also some questionnaires were developed for an assessment of control of a disease [10-13]. To a lesser extent the same occurred and for allergic rhinitis [14-16]. Nevertheless, it wasn't developed any questionnaire for simultaneous control of asthma and allergic rhinitis. Actually, only Rhinasthma [15] made attempt, but the questionnaire was intended for an assessment of the quality of life connected with influence of these diseases.